Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1B |
| 2 |
Merck
MRK
|
+$986M |
| 3 |
Abbott
ABT
|
+$969M |
| 4 |
NVIDIA
NVDA
|
+$967M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$814M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.46B |
| 2 |
Morgan Stanley
MS
|
+$910M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$909M |
| 4 |
Coca-Cola
KO
|
+$745M |
| 5 |
Arista Networks
ANET
|
+$692M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.51% |
| 2 | Technology | 19.42% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
NovaGold Resources
NG
$2.78B
| $4.04M | ﹤0.01% |
1,012,631
+17,542
| +2% | +$94.3K |
|
1277
Trex
TREX
$4.89B
| $4.03M | ﹤0.01% |
+61,439
| New | +$3.43M |
|
|
SASR
1278
DELISTED
Sandy Spring Bancorp Inc
SASR
| $4.02M | ﹤0.01% |
177,372
-8,580
| -5% | -$197K |
|
1279
Grupo Aeroportuario del Sureste
ASR
$8.36B
| $3.99M | ﹤0.01% |
14,357
-2,114
| -13% | -$610K |
|
1280
Coherent
COHR
$63.3B
| $3.98M | ﹤0.01% |
78,167
-3,267,221
| -98% | -$121M |
|
1281
Spyre Therapeutics
SYRE
$9.11B
| $3.97M | ﹤0.01% |
+352,767
| New | +$1.67M |
|
1282
Carlisle Companies
CSL
$14.8B
| $3.97M | ﹤0.01% |
15,467
-12,051
| -44% | -$2.67M |
|
1283
Canadian Imperial Bank of Commerce
CM
$109B
| $3.97M | ﹤0.01% |
92,780
+30,226
| +48% | +$1.28M |
|
1284
CGI
GIB
$15.1B
| $3.96M | ﹤0.01% |
37,513
-7,842
| -17% | -$799K |
|
1285
Nasdaq
NDAQ
$52.6B
| $3.86M | ﹤0.01% |
77,392
-11,124
| -13% | -$603K |
|
1286
Napco Security Technologies
NSSC
$1.36B
| $3.84M | ﹤0.01% |
110,957
-16,135
| -13% | -$563K |
|
|
NPKI
1287
NPK International
NPKI
$1.12B
| $3.8M | ﹤0.01% |
726,500
+447,900
| +161% | +$1.85M |
|
1288
OneSpan
OSPN
$588M
| $3.8M | ﹤0.01% |
255,755
+204,834
| +402% | +$3.19M |
|
1289
Innovative Industrial Properties
IIPR
$1.7B
| $3.79M | ﹤0.01% |
51,944
-3,207
| -6% | -$226K |
|
1290
DNOW Inc
DNOW
$2.6B
| $3.75M | ﹤0.01% |
361,800
+292,573
| +423% | +$2.94M |
|
1291
Sibanye-Stillwater
SBSW
$6.77B
| $3.67M | ﹤0.01% |
588,488
-65,743
| -10% | -$518K |
|
|
INBX
1292
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $3.65M | ﹤0.01% |
140,589
+37,692
| +37% | +$880K |
|
1293
Constellium
CSTM
$3.85B
| $3.64M | ﹤0.01% |
211,870
+2,155
| +1% | +$33.1K |
|
1294
SLM Corp
SLM
$5.09B
| $3.61M | ﹤0.01% |
221,352
-35,864
| -14% | -$546K |
|
1295
American Outdoor Brands
AOUT
$161M
| $3.6M | ﹤0.01% |
414,929
-196,368
| -32% | -$1.63M |
|
1296
Standex International
SXI
$3.78B
| $3.58M | ﹤0.01% |
25,318
-36,792
| -59% | -$4.86M |
|
1297
Magna International
MGA
$18.2B
| $3.56M | ﹤0.01% |
62,907
+11,320
| +22% | +$600K |
|
|
PDM
1298
Piedmont Realty Trust
PDM
$1.24B
| $3.55M | ﹤0.01% |
488,854
-24,103
| -5% | -$160K |
|
1299
Vipshop
VIPS
$7.47B
| $3.55M | ﹤0.01% |
215,105
-14,552
| -6% | -$228K |
|
1300
PMV Pharmaceuticals
PMVP
$59.7M
| $3.54M | ﹤0.01% |
565,943
-304,111
| -35% | -$1.59M |
|
Similar funds
Wellington Management Group's Q2 2023 Portfolio in Review
As of Q2 2023, Wellington Management Group held 2,099 positions worth $527B, up 4.5% from $505B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Wellington Management Group's Q2 2023 filing shows 119 new, 718 increased, 815 reduced and 304 closed positions. Its largest new stake was Kenvue: 10,602,707 shares worth $280M. The largest sale was Eli Lilly, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2023 buy was Kenvue: 10,602,707 shares worth $280M.
- Wellington Management Group added most to Gilead Sciences in Q2 2023, an estimated $1B increase.
- Wellington Management Group's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $2.46B.
- Wellington Management Group fully exited Syneos Health, Inc. Class A Common Stock in Q2 2023, selling an estimated $267M.
- Wellington Management Group's ten largest holdings make up 20% of its $527B portfolio in Q2 2023.
- Wellington Management Group opened 119 new positions and closed 304 in Q2 2023.
- Wellington Management Group's portfolio value rose 4.5% quarter-over-quarter to $527B.
Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.